Melanotic neuroectodermal tumor of infancy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Melanotic neuroectodermal tumor of infancy
Melanotic neuroectodermal tumor of infancy
Synonyms	Progonoma
Pronounce	N/A
Specialty	N/A
Symptoms	Rapidly growing mass, often in the jaw
Complications	Potential for malignancy
Onset	Typically within the first year of life
Duration	Variable
Types	N/A
Causes	Unknown
Risks	Unknown
Diagnosis	Histopathology, imaging studies
Differential diagnosis	Neuroblastoma, rhabdomyosarcoma, teratoma
Prevention	N/A
Treatment	Surgical resection
Medication	N/A
Prognosis	Generally good with complete resection
Frequency	Rare
Deaths	N/A

Melanotic neuroectodermal tumor of infancy - Histological section

Melanotic neuroectodermal tumor of infancy - Radiographic image

Melanotic Neuroectodermal Tumor of Infancy (MNTI) is a rare, usually benign tumor that predominantly occurs in the maxilla of infants during their first year of life. Despite its benign nature, MNTI can be locally aggressive and has a high recurrence rate. The tumor is characterized by its rapid expansile growth, leading to significant facial asymmetry and displacement of teeth. Histologically, it is distinguished by its biphasic population of cells: pigmented melanin-containing cells and non-pigmented neuroblastic cells.

Etiology and Pathogenesis

The exact cause of MNTI remains unknown. However, it is believed to originate from neural crest cells, which contribute to the development of the peripheral nervous system and melanocytes. This theory is supported by the tumor's expression of markers that are characteristic of neural crest derivatives.

Clinical Presentation

MNTI typically presents within the first year of life, with a slight male predilection. The most common site of occurrence is the anterior maxilla, although cases have been reported in the mandible, skull, brain, and even in the epididymis. Clinically, it manifests as a rapidly enlarging, firm mass that can cause displacement of teeth, facial asymmetry, and occasionally, ulceration of the overlying mucosa.

Diagnosis

The diagnosis of MNTI is primarily based on clinical and radiographic findings, supported by histopathological examination. Radiographically, MNTI appears as a well-demarcated, radiolucent lesion, often causing displacement of adjacent teeth. Histologically, the tumor is characterized by a biphasic pattern of melanin-containing epithelioid cells and neuroblastic cells, with the presence of a fibrous stroma.

Treatment and Prognosis

Surgical excision is the treatment of choice for MNTI. Complete resection with clear margins is essential to minimize the risk of recurrence. Despite its benign nature, MNTI has a relatively high recurrence rate, necessitating close follow-up. The prognosis is generally good, with rare reports of malignant transformation.

Epidemiology

MNTI is a rare tumor, with a limited number of cases reported in the literature. It predominantly affects infants, with most cases presenting within the first year of life.

Summary

Melanotic Neuroectodermal Tumor of Infancy is a rare, usually benign tumor that poses significant challenges due to its rapid growth and potential for recurrence. Early diagnosis and complete surgical resection are crucial for a favorable outcome. Ongoing research into the tumor's etiology and pathogenesis may provide insights into more targeted therapies in the future.

   This article is a medical stub. You can help WikiMD by expanding it!